Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1075
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3195
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Rationale And Objectives: The aim of this study is to develop a deep learning-based multimodal feature interaction-guided fusion (DL-MFIF) framework that integrates macroscopic information from computed tomography (CT) images with microscopic information from whole-slide images (WSIs) to predict the epidermal growth factor receptor (EGFR) mutations of primary lung adenocarcinoma in patients with advanced-stage disease.
Materials And Methods: Data from 396 patients with lung adenocarcinoma across two medical institutions were analyzed. The data from 243 cases were divided into a training set (n=145) and an internal validation set (n=98) in a 6:4 ratio, and data from an additional 153 cases from another medical institution were included as an external validation set. All cases included CT scan images and WSIs. To integrate multimodal information, we developed the DL-MFIF framework, which leverages deep learning techniques to capture the interactions between radiomic macrofeatures derived from CT images and microfeatures obtained from WSIs.
Results: Compared to other classification models, the DL-MFIF model achieved significantly higher area under the curve (AUC) values. Specifically, the model outperformed others on both the internal validation set (AUC=0.856, accuracy=0.750) and the external validation set (AUC=0.817, accuracy=0.708). Decision curve analysis (DCA) demonstrated that the model provided superior net benefits(range 0.15-0.87). Delong's test for external validation confirmed the statistical significance of the results (P<0.05).
Conclusion: The DL-MFIF model demonstrated excellent performance in evaluating and distinguishing the EGFR in patients with advanced lung adenocarcinoma. This model effectively aids radiologists in accurately classifying EGFR mutations in patients with primary lung adenocarcinoma, thereby improving treatment outcomes for this population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acra.2025.04.071 | DOI Listing |